✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Biocon Ltd.

BIOCON

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹51,199 Cr.
P/E
50.53

Biocon Ltd.

  • Biocon
  • Concord Biotech
  • Advanced Enzyme
  • TJI Pharma
FAQs on Biocon Ltd. Shareprice

Biocon has given better returns compared to its competitors.
Biocon has grown at ~7.99% over the last 1yrs while peers have grown at a median rate of 6.46%

Biocon is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Biocon is 51.6, while 3 year average PE is 54.74.
Also latest EV/EBITDA of Biocon is 21.02 while 3yr average is 20.43.

View FAQ's On Business
Growth Table
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Balance Sheet
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Cash Flow
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Quarterly Results
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Biocon Ltd. Financials

Biocon balance sheet is weak and might have solvency issues

The net debt of Biocon is decreasing.
Latest net debt of Biocon is ₹9,515 Crs as of Mar-25.
This is less than Mar-24 when it was ₹11,212 Crs.

The profit is oscillating.
The profit of Biocon is ₹1,013 Crs for Mar 2025, ₹1,022 Crs for Mar 2024 and ₹463 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biocon latest dividend payout ratio is 5.92% and 3yr average dividend payout ratio is 16.91%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech